Rimegepant for the treatment of migraine (with or without aura) in children and adolescents

Go Back to All Clinical Trials

Rimegepant for the treatment of migraine (with or without aura) in children and adolescents

Brief description of study

The main purpose of this study is to learn how well the study drug works and how safe the study drug is in children and young people compared with placebo. A placebo is an inactive material that looks like the study drug but does not contain any active study drug. Researchers use a placebo to see if the study drug works better or is safer than taking nothing.

Clinical Study Identifier: s21-00736

ClinicalTrials.gov Identifier: NCT04649242

Principal Investigator: Vijaya L Atluru.

Other Investigator: Chaula Kharode.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies